TP53 mutated AML patients show a characteristic genomic instability with a complex karyotype (CK) and various patterns of co-mutations according to the TP53 allelic state, making this setting particularly prone to chemoresistance [30,31]. This evidence concerns the gene TP53 and acute myeloid leukemia.